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Lemon balm (Melissa oﬃcinalis L.) is a member of the Lamiaceae family with a long story of human con-
sumption. It has been consumed for decades, directly in food and as a decoction or an infusion for its
medicinal purposes. In this manuscript, a detailed chemical characterization of the decoction of this plant
is described, encompassing antimicrobial, antioxidant and antitumor activities. Rosmarinic acid and litho-
spermic acid A were the most abundant phenolic compounds. Quinic acid, fructose, glucose and γ-toco-
pherol were the most abundant within their groups of molecules. M. oﬃcinalis decoctions were active
against a wide range of microorganisms, Pseudomonas aeruginosa and Salmonella typhimurium, and
Penicillium funiculosum being the most sensitive bacteria and fungi, respectively. The growth inhibition of
diﬀerent human tumor cell lines (mainly MCF-7 and HepG2) was also observed, as also high free radical
scavenging activity and reducing power. This manuscript highlights some beneﬁcial eﬀects of these func-
tional beverages.
1. Introduction
Medicinal herbs are used for their benefits towards health and
are also incorporated into cosmetics, food, pharmaceuticals
and other products designed for human consumption. Essen-
tial oils, polyphenols, terpenes, alkaloids, steroids and
other compounds of the secondary metabolism of plants are
examples of the many compounds present in the Plant
kingdom that have been used for diﬀerent purposes. The use
of these products is limited since they require suitable
methods of extraction and purification, but they have gained
considerable interest from researchers and consumers for the
advantages in comparison with synthesized molecules.1
Melissa oﬃcinalis L., commonly known as lemon balm, is a
member of the Lamiaceae family that has been used for centu-
ries for its outstanding traditional, medicinal eﬀects on health
and against illnesses. It is credited for its antibacterial, anti-
fungal, and anti-inflammatory eﬀects. Furthermore, it acts as
an expectorant, relieves digestion, headaches and rheuma-
tism.2,3 Recently, apart from some empirical claims of its
applicability, other eﬀects have been discovered for this plant,
namely against neurodegenerative diseases, and antitumor,
antiproliferative, anticholinesterase, antioxidant and anti-Alz-
heimer eﬀects.2,4 Further uses have also been explored, namely
as a food ingredient for stabilization and preservation.5 The
beneficial eﬀects found in the extracts of M. oﬃcinalis could
in part be attributed to its phenolic compounds, namely the
caﬀeic acid dimer rosmarinic acid, and other caﬀeic acid
derivatives.3
The most consumed drinks in the world are “teas”. They
are consumed as functional beverages, thanks to the beneficial
properties of the plants used in them. The two most important
methods of preparation of “teas” are infusions and decoctions,
with the latter being the most common and more eﬀective for
a better extraction of larger molecules like tannins and other
hard extracting ones.6 Some studies, comparing infusions and
decoctions have proven that the decoctions have better extract-
ing capacity and this can be translated in higher levels of phe-
nolic compounds and, therefore, increased bioactivity.7,8
Given the outstanding eﬀects of lemon balm on human
health and its potential as a functional beverage, in the
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present work, its decoctions have been chemically character-
ized (phenolic compounds, organic acids, sugars and toco-
pherols) and evaluated with respect to its antimicrobial,
antioxidant and antitumor in vitro eﬀects.
2. Materials and methods
2.1. Sample and decoction preparation
Melissa oﬃcinalis L. dry leaves were provided by the company
Pragmático Aroma Lda. (“Mais Ervas”) based in Trás-os-
Montes, Portugal. After confirmation of the taxonomical
identification, the samples were subjected to a decoction
extraction, in which 1 g of the plants was added to 200 mL of
cold distilled water. After heating, it was left to boil for 5 min
and stand at room temperature for 5 more minutes. After fil-
tration through a Whatman no. 4 filter paper, the obtained
decoctions were frozen and lyophilized and all the assays were
performed using these samples. The extractions and all the
assays were carried out in triplicate and the results were
expressed as mean values ± standard deviations (SD).
2.2. Standards and reagents
Acetonitrile, n-hexane, ethyl acetate (HPLC grade) and sulphu-
ric acid were acquired from Fisher Scientific (Lisbon, Portu-
gal). Formic acid was purchased from Panreac (Barcelona,
Spain). Sugar standards (D(−)-fructose, D(+)-glucose anhydrous
and D(+)-sucrose), organic acid standards (malic, shikimic,
oxalic and quinic acids), tocopherol standards (α, β, γ, and
δ isoforms), trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-car-
boxylic acid), acetic acid, ellipticine, sulforhodamine B (SRB),
trypan blue, trichloroacetic acid (TCA), phosphate buﬀered
saline (PBS), and Tris buﬀer were acquired from Sigma Chemi-
cal Co. (Saint Louis, MO, USA). Dimethyl sulfoxide (DMSO)
was obtained from Merck (KGaA, Germany). Phenolic com-
pound standards (caﬀeic and rosmarinic acid) were purchased
from Extrasynthese (Genay, France). 2,2-Diphenyl-1-picryl-
hydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, MA,
USA). Fetal bovine serum (FBS), L-glutamine, Hank’s balanced
salt solution (HBSS), trypsin-EDTA (ethylenediaminetetraacetic
acid), nonessential amino acid solution (2 mM), penicillin/
streptomycin solution (100 U mL−1 and 100 mg mL−1, respect-
ively), RPMI-1640, and DMEM media were acquired from
HyClone (Logan, UT, USA). Mueller–Hinton agar (MH) and
malt agar (MA) were obtained from the Institute of Immuno-
logy and Virology, Torlak (Belgrade, Serbia). Racemic tocol
(50 mg mL−1) was purchased from Matreya (Pleasant Gap,
PA, USA). All other chemicals were obtained from oﬃcial scien-
tific retailers. Water was treated by means of a Milli-Q water
purification system (TGI Pure Water Systems, Greenville,
SC, USA).
2.3. Chemical characterization
2.3.1 Phenolic compounds. Phenolic compounds were
determined by HPLC (Hewlett-Packard 1100, Agilent Techno-
logies, Santa Clara, CA, USA) as previously described by Barros
et al.9 Double online detection was carried out in a DAD using
280 nm as the preferred wavelength and using a mass spectro-
meter connected to the HPLC system via the DAD cell outlet.
Mass spectrometric detection was performed by means of an
API 3200 (Applied Biosystems, Darmstadt, Germany) triple
quadrupole-ion trap analyser equipped with an ESI source.
Spectra were recorded in negative ion mode between m/z 100
and 1700. The phenolic compounds were identified by com-
paring their retention time, UV-vis and mass spectra with
those obtained from standard solutions, when available.
Otherwise, the compounds were tentatively identified by com-
paring the obtained information with available data in our
compound library or with that reported in the literature. For
quantitative analysis, a 5-level calibration curve was obtained
by plotting the areas of the peaks recorded at 280 nm against
known concentrations (1–100 mg mL−1) of phenolic standards,
i.e., caﬀeic acid (y = 359x + 488.4; R2 = 0.999) and rosmarinic
acid (y = 312.2x − 424.06; R2 = 0.999). Compound quantifi-
cation was performed through the calibration curve of the phe-
nolic standard of the same group. The results were expressed
in mg per g of lyophilized decoctions.
2.3.2. Organic acids. Organic acids were determined fol-
lowing a procedure previously described by Pinela et al.10 Ana-
lyses were performed on a Shimadzu 20A series ultra-fast
liquid chromatograph (UFLC, Shimadzu Cooperation, Kyoto,
Japan) coupled to a diode array detector (DAD, Shimadzu),
using 215 nm and 245 nm (for ascorbic acid) as the preferred
wavelengths. Separation was achieved on a SphereClone
(Phenomenex, Torrance, CA, USA) reverse phase C18 column
(5 µm, 250 mm × 4.6 mm i.d) thermostated at 35 °C. Analytes
were eluted with 3.6 mM sulphuric acid at a flow-rate of
0.8 mL min−1. The organic acids found were quantified by
comparison of peak areas recorded at 215 nm with calibration
curves obtained from commercial standards of each com-
pound: oxalic acid (y = 9 × 106x + 377 946; R2 = 0.994); quinic
acid (y = 612 327x + 16 563; R2 = 1); malic acid (y = 863 548x +
55 591; R2 = 0.999); shikimic acid (y = 8 × 107x + 55 079; R2 =
0.999); citric acid (y = 1 × 106x + 16 276; R2 = 1); succinic acid
(y = 603 298x + 4994.1; R2 = 1); fumaric acid (y = 148 083x +
96 092; R2 = 1). The results were expressed in mg per g of
lyophilized decoctions.
2.3.3. Free sugars. Free sugars were determined by HPLC
coupled to a refractive index (RI) detector as described by
Pinela et al.10 The equipment consisted of a pump (Knauer,
Smartline System 1000, Berlin, Germany), a degasser (Smart
line Manager 5000), an autosampler (AS-2057 Jasco, Easton,
MD, USA), and a RI detector (Knauer Smartline 2300). The
chromatographic separation was achieved with an Eurospher
100-5 NH2 column (5 μm, 250 mm × 4.6 mm i.d., Knauer) oper-
ating at 35 °C (7971 R Grace oven). The mobile phase was
acetonitrile/deionized water, 70 : 30 (v/v) at a flow rate of 1 mL
min−1. The identification was achieved by comparing the rela-
tive retention times of the sample peaks with standards.
Quantification was made by the internal standard method,
and the results are expressed in mg per g of lyophilized
decoctions.
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2.3.4. Tocopherols. Tocopherols were determined by fol-
lowing a procedure previously described by Guimarães et al.11
The HPLC system as described above for sugar analysis, was
connected to a fluorescence detector (FP-2020; Jasco, Easton,
MD, USA) programmed for excitation at 290 nm and emission
at 330 nm. The chromatographic separation was achieved with
a polyamide II normal-phase column (5 μm, 250 mm × 4.6 mm
i.d., YMC Waters), operating at 35 °C. The mobile phase used
was a mixture of n-hexane and ethyl acetate (70 : 30, v/v) at a
flow rate of 1 mL min−1. The compounds were identified by
chromatographic comparisons to authentic standards. Quanti-
fication was based on the fluorescence signal response, using
the internal standard method. The tocopherol contents in the
samples were expressed in μg per g of lyophilized decoctions.
2.4. Evaluation of bioactive properties
2.4.1. General. Lyophilized decoctions were redissolved in
water (5 mg mL−1 for antimicrobial and antioxidant activity
evaluation, or 8 mg mL−1 for antitumor activity and hepato-
toxicity evaluation). The final solutions were further diluted to
diﬀerent concentrations to be subjected to the distinct in vitro
assays.
2.4.2. Antibacterial activity. The methodology previously
described by Petrović et al.12 and Vieira et al.13 was followed.
The following Gram-negative bacteria were used: Escherichia
coli (ATCC (American type culture collection) 35210), Pseudo-
monas aeruginosa (ATCC 27853), Salmonella typhimurium
(ATCC 13311), Enterobacter cloacae (ATCC 35030), and Gram-
positive bacteria: Staphylococcus aureus (ATCC 6538), Bacillus
cereus (clinical isolate), Micrococcus flavus (ATCC 10240), and
Listeria monocytogenes (NCTC (National collection of type cul-
tures) 7973). These microorganisms were obtained from the
Mycological Laboratory, Department of Plant Physiology, Insti-
tute for Biological Research “Siniša Stanković” at the University
of Belgrade in Serbia. A fresh overnight culture of bacteria was
adjusted with a spectrophotometer to a concentration of 1 ×
105 CFU mL−1. The requested colony forming units (CFU)
mL−1 corresponded to a bacterial suspension determined
using a spectrophotometer at 625 nm. Dilutions of the inocula
were cultured on solid medium to verify the absence of con-
tamination and to check the validity of the inoculum. The
sample solutions were pipetted into the wells containing
100 μL of Tryptic Soy Broth (TSB), with 10 μL of the inoculum
being added to all the wells. The microplates were incubated
for 24 h at 37 °C. The MIC (minimal inhibitory concentration)
of the samples was determined by adding 40 μL of iodonitro-
tetrazolium chloride (INT) (0.2 mg mL−1) and by incubation at
37 °C for 30 min. The lowest concentration that produced a
significant inhibition (around 50%) of the growth of the bac-
teria in comparison with the positive control was identified as
the MIC. The MICs obtained from the susceptibility testing of
various bacteria to the tested samples were also determined by
a colorimetric microbial viability assay based on the reduction
of INT color and compared with the positive control for each
bacterial strain. MBC (minimal bactericidal concentration) was
determined by serial sub-cultivation of 10 μL into microplates
containing 100 μL of TSB. The lowest concentration that
showed no growth after this sub-culturing was regarded as the
MBC. Streptomycin and ampicillin were used as positive con-
trols, while 5% dimethyl sulfoxide (DMSO) was used as a nega-
tive control. The results of MIC and MBC were expressed in mg
per mL of the aqueous solutions of the lyophilized decoctions.
2.4.3. Antifungal activity. The methodology previously
described by Petrović et al.12 and Vieira et al.13 was followed.
The following microfungi were used: Aspergillus fumigatus
(ATCC 1022), Aspergillus ochraceus (ATCC 12066), Aspergillus
versicolor (ATCC 11730), Aspergillus niger (ATCC 6275), Tricho-
derma viride (IAM (Culture Collection, Centre for Cellular and
Molecular Research, Institute of Molecular and Cellular Bio-
sciences, The University of Tokyo, Japan) 5061), Penicillium
funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC
9112) and Penicillium verrucosum var. cyclopium (food isolate).
These organisms were also obtained from theMycological Labo-
ratory, Department of Plant Physiology, Institute for Biological
Research “Siniša Stanković” at the University of Belgrade in
Serbia. The micromycetes were maintained on malt agar (MA)
and the cultures were stored at 4 °C and sub-cultured once a
month. The fungal spores were washed from the surface of
agar plates with sterile 0.85% saline containing 0.1% Tween
80 (v/v). The spore suspension was adjusted with sterile saline
to a concentration of approximately 1.0 × 105 in a final volume
of 100 μL per well. The inocula were stored at 4 °C for further
use. Dilutions of the inocula were cultured on solid MA to
verify the absence of contamination and to check the validity
of the inoculum. The MIC determination was performed by a
serial dilution technique using 96-well microplates. The
sample solutions were added to the broth malt medium with
the fungal inoculum. The microplates were incubated for 72 h
at 28 °C.14 The lowest concentrations without visible growth
(using a binocular microscope) were defined as the MIC. The
minimum fungicidal concentrations (MFCs) were determined
by serial sub-cultivation of 2 μL in microtiter plates containing
100 μL of malt broth per well and further by incubation for
72 h at 28 °C. The lowest concentration with no visible growth
was defined as the MFC, indicating 99.5% killing of the origi-
nal inoculum. 5% DMSO was used as a negative control, while
bifonazole and ketoconazole were used as positive controls.
The results of MIC and MFC were expressed as mg per mL of
the aqueous solutions of the lyophilized decoctions.
2.4.4. Antioxidant activity. The DPPH radical-scavenging
activity was evaluated using an ELX800 microplate reader (Bio-
Tek Instruments, Inc.; Winooski, VT, USA) and calculated as a
percentage of DPPH discolouration after 1 hour of incubation
with the antioxidant extract, using the formula: [(ADPPH − AS)/
ADPPH] × 100, where AS is the absorbance of the solution con-
taining the sample at 515 nm, and ADPPH is the absorbance of
the DPPH solution. Reducing power was evaluated by the
capacity to reduce Fe3+ into Fe2+, measuring the absorbance at
690 nm in the microplate reader mentioned above. Inhibition
of β-carotene bleaching was evaluated through the β-carotene/
linoleate assay; the neutralization of linoleate free radicals
avoids β-carotene bleaching, which is measured by the
Paper Food & Function
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formula: (β-carotene absorbance after 2 h of assay/initial absor-
bance) × 100. Lipid peroxidation inhibition in porcine (Sus
scrofa) brain homogenates was evaluated by the decrease in
thiobarbituric acid reactive substances (TBARS); the colour
intensity of the malondialdehyde-thiobarbituric acid
(MDA-TBA) was measured by its absorbance at 532 nm; the
inhibition ratio (%) was calculated using the following
formula: [(A − B)/A] × 100%, where A and B were the absor-
bances of the control and the sample solution, respectively.9
Trolox was used as a positive control. The results were
expressed as EC50 values (sample concentration providing 50%
of the antioxidant activity or 0.5 of absorbance in the reducing
power assay) in μg per mL of the aqueous solutions of the
lyophilized decoctions.
2.4.5. Antitumor activity and hepatotoxicity. Four human
tumor cell lines were tested: MCF7 (breast adenocarcinoma),
NCI-H460 (non-small cell lung carcinoma), HeLa (cervical
carcinoma) and HepG2 (hepatocellular carcinoma). Cells were
routinely maintained as adherent cell cultures in RPMI-
1640 medium containing 10% heat-inactivated FBS and 2 mM
glutamine at 37 °C, in a humidified air incubator containing
5% CO2. Each cell line was plated at an appropriate density
(7.5 × 103 cells per well for MCF7 and NCI-H460 or 1.0 × 104
cells per well for HeLa and HepG2) in 96-well plates.
For hepatotoxicity evaluation, a cell culture was prepared
from a fresh porcine liver obtained from a local slaughter
house, and it was designed as PLP2. Briefly, the liver tissues
were rinsed in Hank’s balanced salt solution containing 100 U
mL−1 penicillin, 100 µg mL−1 streptomycin and were divided
into 1 × 1 mm3 explants. Some of these explants were placed in
25 cm2 tissue flasks in DMEM medium supplemented with
10% fetal bovine serum, 2 mM nonessential amino acids and
100 U mL−1 penicillin, 100 mg mL−1 streptomycin and incu-
bated at 37 °C under a humidified atmosphere containing 5%
CO2. The medium was changed every two days. Cultivation of
the cells was continued with direct monitoring every two
to three days using a phase contrast microscope. Before the
confluence was reached, the cells were subcultured and plated
in 96-well plates at a density of 1.0 × 104 cells per well, and
cultivated in DMEM medium with 10% FBS, 100 U mL−1
penicillin and 100 µg mL−1 streptomycin.15
The sulphorhodamine B assay was performed according
to a procedure previously described by Guimarães et al.11
Ellipticine was used as a positive control. The results were
expressed as GI50 values (sample concentration that inhibited
50% of the net cell growth) in µg per mL of the aqueous
solutions of the lyophilized decoctions.
3. Results and discussion
3.1. Chemical characterization
Fig. 1 shows a chromatogram with the phenolic profile of
M. oﬃcinalis decoctions recorded at 280 nm. Twenty com-
pounds could be detected and identified, mostly corres-
ponding to caﬀeic acid derivatives. Peak characteristics and
tentative identifications based on their UV and mass spectra
by comparing with the available literature16–22 are presented in
Table 1. Although there are studies about the phenolic profile
in aqueous or alcoholic extracts of M. oﬃcinalis,3,23–30 as far as
we know, this is the first report regarding phenolic characteriz-
ation in decoctions of this plant. In a previous study,3 the
phenolic characterization of infusions obtained from diﬀerent
samples of M. oﬃcinalis (cultivated, in vitro cultured, commer-
cial granulate and bag) had been already performed, being the
profiles similar to the one observed in the decoctions studied
herein.
Compound 1 was identified as 3-(3,4-dihydroxyphenyl)-
lactic acid, based on its fragmentation pattern,17 and
previous identification in M. oﬃcinalis infusions.3 Compounds
5 ([M − H]− at m/z 179) and 15 ([M − H]− at m/z 359) were posi-
tively identified as caﬀeic and rosmarinic acids according to
their retention time, mass and UV-vis characteristics by com-
parison with the commercial standards. Compound 14, with
Fig. 1 Phenolic proﬁle of M. oﬃcinalis decoction, recorded at 280 nm.
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characteristics similar to compound 15, was tentatively identi-
fied as the cis isomer of rosmarinic acid. Hydroxycinnamoyl cis
derivatives would be expected to elute before the corres-
ponding trans ones, as observed after UV irradiation (366 nm,
24 h) in our laboratory. Compounds 6 ([M − H]− at m/z 439)
and 12 ([M − H]− at m/z 521) yielded a fragment at m/z 359
(rosmarinic acid) from the loss of 80 mu (sulphate moiety) and
162 mu (hexoside moiety), respectively, which allowed their
tentative identification as sulphated and hexoside derivatives
of rosmarinic acid, as previously reported in M. oﬃcinalis infu-
sions.3 Similarly, compound 3 ([M − H]− at m/z 341) was
assigned as a caﬀeic acid hexoside. Compounds 2 ([M − H]− at
m/z 311), 4 ([M − H]− at m/z 325) and 10 ([M − H]− at m/z 473)
were tentatively identified as hydroxycinnamoyl tartaric esters,
namely caftaric (caﬀeoyltartaric acid), fertaric (feruloyltartaric
acid) and cichoric (dicaﬀeoyltartaric acid) acids, respectively,
based on their mass spectra.20 Compound 8 ([M − H]− at m/z
357) presented a fragmentation pattern and the UV-vis
spectra that allowed its identification as the caﬀeic acid dimer
prolithospermic acid.19,20
Compounds 7, 9, 16, 18 and 19 were associated with caﬀeic
acid trimers. Compound 7 presented a pseudomolecular ion
[M − H]− at m/z 571 releasing various fragments from the com-
bination of successive losses of 44 mu (CO2) and 197 mu (di-
hydroxyphenyl-lactic acid). These characteristics are similar to
the ones described for yunnaneic acid E,31 an identity that was
tentatively associated with this compound. Compounds 9 and
18 showed the same pseudomolecular ion ([M − H]− at m/z
537), which may match the structure of salvianolic acids H/I
and lithospermic acid A. They were tentatively assigned as
lithospermic acid A isomers due to the absence of a fragment
m/z 339, as reported in the literature.17,20,22 Compound 18 was
assigned as lithospermic acid A that was expected to elute later
than rosmarinic acid.17,18,20 Similar behaviour was observed in
the infusions of M. oﬃcinalis.3 Compounds 16 and 19 pre-
sented a pseudomolecular ion [M − H]− at m/z 493, which
together with their characteristic fragment ions at m/z 313, 295
and 197 20,22 and UV spectra allowed assigning them as salvia-
nolic acid A isomers. Compound 16 was tentatively identified
as salvianolic acid A that was expected to elute earlier than
lithospermic acid A, as previously reported,3 whereas com-
pound 19 was associated with a salvianolic acid A isomer.
Compound 13 showed a pseudomolecular ion [M − H]− at
m/z 719 releasing a main MS2 fragment at m/z 359 ([M − 2H]2−,
rosmarinic acid) as well as other fragments characteristic of
caﬀeic acid oligomers, which allowed its identification as
sagerinic acid, a rosmarinic acid dimer that was also pre-
viously identified in M. oﬃcinalis infusions.3
No definite structure could be proposed for compounds 11
([M − H]− at m/z 553), 17 ([M − H]− at m/z 829) and 20
([M − H]− at m/z 715), although their fragmentation pattern
allowed assignment of them as caﬀeic acid oligomers; further-
more, the presence of a common MS2 fragment at m/z 491
that may be attributed to salvianolic acid C, might suggest
that they are derivatives of that compound. Compounds
with similar characteristics as 17 and 20 were previously
detected3,30 in the samples of M. oﬃcinalis, although no struc-
ture was proposed, either.
Table 1 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, tentative identiﬁcation of phenolic
compounds in M. oﬃcinalis decoctions
Compound
Rt
(min)
λmax
(nm)
Molecular
ion [M − H]−
(m/z) MS2 (m/z) Tentative identification
1 4.57 280 197 179(92), 135(100) 3-(3,4-Dihydroxyphenyl)-lactic acid
2 4.91 330 311 179(100), 149(98), 135(31) Caftaric acid
3 6.91 320 341 179(100), 149(7), 135(31) Caﬀeic acid hexoside
4 8.13 324 325 193(100), 149(11), 145(25), 134(43) Fertaric acid
5 11.19 324 179 135(100) Caﬀeic acid
6 12.01 330 439 359(12), 179(10), 161(46), 135(22) Sulphated rosmarinic acid
7 12.53 270 571 527(14), 483(61), 439(52), 329(23), 259(22), 241(49),
197(100), 179(77), 135(98)
Yunnaneic acid E
8 13.05 270, 310sh 357 313(30), 269(100), 203(56), 159(61), 109(50) Prolithospermic acid
9 13.85 276, 324sh 537 493(57), 359(13), 313(27), 295(100), 269(27),
197(19), 179(78), 135(45)
Lithospermic acid A isomer
10 14.95 328 473 311(19), 293(19), 179(75), 149(100), 135(28) Chicoric acid
11 17.54 266, 336sh 553 491(9), 359(3), 311(5), 197(3), 179(21), 161(12), 135(100) Salvianolic acid C derivative
12 18.88 322 521 359(100), 197(16), 179(32), 161(72), 135(16) Rosmarinic acid hexoside
13 21.17 284, 328sh 719 539(17), 521(15), 359(100), 197(22), 179(26),
161(81), 135(7)
Sagerinic acid
14 23.32 328 359 197(35), 179(34), 161(100), 135(15) cis-Rosmarinic acid
15 24.03 330 359 197(83), 179(70), 161(100), 135(40) trans-Rosmarinic acid
16 27.60 324 493 359(78), 313(8), 295(52), 269(7), 197(33), 179(44) Salvianolic acid A
17 28.42 328 829 667(86), 535(100), 491(21), 311(39), 293(15), 179(10) Salvianolic acid C derivative
18 30.11 288, 326sh 537 493(53), 359(100), 313(5), 295(18), 269(3),
197(44), 179(64)
Lithospermic acid A
19 31.32 320 493 359(100), 313(5), 295(6), 269(4), 197(14), 179(34) Salvianolic acid A isomer
20 35.17 288, 320sh 715 535(100), 491(38), 311(69), 293(4), 179(5), 135(20) Salvianolic acid C derivative
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Quantification of the detected phenolic compounds
expressed as rosmarinic or caﬀeic acid equivalents is shown in
Table 2. Rosmarinic acid was the most abundant phenolic
compound present in the decoctions; many authors have also
reported this compound as the main phenolic compound in
this species.3,24,26,28–30 Luteolin derivatives have also been
reported as relevant phenolics in M. oﬃcinalis,3,23,25,28,30 but
this type of derivatives (with low hydrophilicity) was absent in
the decoction of M. oﬃcinalis. Rosmarinic acid has been
reported as displaying high antioxidant and antibacterial
activity.32
In terms of organic acids, the decoctions of M. oﬃcinalis
presented oxalic, quinic, malic, shikimic, citric, succinic and
fumaric acids. The higher quantities were found for quinic
acid and the lower ones for fumaric acid as detailed in Table 3.
When compared to decoctions of other plant species, namely
Matricaria recutita L., quinic acid proved to be higher for
M. oﬃcinalis;33 furthermore, lemon balm decoctions contained
higher contents in all organic acids when compared to Juglans
regia L. leaves, although ascorbic acid was found in the latter
species.34 Quinic acid is a normal constituent of our diet,
capable of conversion to tryptophan and nicotinamide via the
GI tract microflora, thus providing an in situ physiological
source of these essential metabolic ingredients to humans.
Pero, Lund, & Leanderson35 conducted a clinical trial that con-
firmed the eﬃcacy of quinic acid as an antioxidant, and
extends its mode of action to include a basic nutritional
benefit due to the enhanced metabolism of both tryptophan
and nicotinamide, which are simultaneously induced by oral
exposure to quinic acid.
The only free sugars detected in the decoctions of M. oﬃci-
nalis were fructose, glucose (the most abundant ones) and tre-
halose as depicted in Table 3. When compared to other
decocted samples like wild Tuberaria lignosa (Sweet) Samp.10,
J. regia34 and Castanea sativa Mill.7, M. oﬃcinalis proved to
have a much lower content of sugars.
Tocopherols, which are isoforms of vitamin E, the most
important lipophilic vitamin for the human metabolism, were
also found in the decoctions (Table 3). Only α- and γ-isoforms
were found, with the latter being the most abundant one. As
expected, the quantity of γ-tocopherol found in these decoc-
tions was lower than the one reported in a previous study with
garden cultivated, in vitro cultured, commercial bag and granu-
lated M. oﬃcinalis plants (results expressed in dry weight and
after extraction with non-polar solvents); this is certainly
related with the lower extractability of these compounds using
water.36
3.2. Bioactive properties
Regarding the decoctions’ antibacterial activity (Table 4), the
most sensitive bacteria were Pseudomonas aeruginosa and Sal-
monella typhimurium, and for the last case even better than the
positive controls. The decoctions gave the same MBC as ampi-
cillin against Staphylococcus aureus, and the same MIC as
streptomycin against P. aeruginosa. In terms of antifungal
activity, M. oﬃcinalis decoctions displayed higher activity, with
Penicillium funiculosum being more sensitive to the decoction
than the two positive controls (bifonazole and ketoconazole).
The behaviour of the decoctions against Aspergillus versicolor,
A. ochraceus, Trichoderma viride and P. ochrochloron was better
than the positive control ketoconazole (lower MICs and MFCs).
The antioxidant activity of the decoctions was determined
by DPPH scavenging activity, reducing power, β-carotene
bleaching inhibition and neutralization of thiobarbituric reac-
tive species. The DPPH scavenging activity and reducing power
of the decoctions were higher than their lipid peroxidation
Table 3 Quantiﬁcation of organic acids, free sugars and tocopherols in
M. oﬃcinalis decoctions
Organic acids Content (mg g−1 lyophilized decoction)
Oxalic 11.8 ± 0.1
Quinic 96.9 ± 0.2
Malic 18.8 ± 0.1
Shikinic 1.80 ± 0.01
Citric 24.1 ± 0.1
Succinic 26 ± 1
Fumaric 0.032 ± 0.001
Total 179 ± 1
Sugars Content (mg g−1 lyophilized decoction)
Fructose 49 ± 4
Glucose 47 ± 1
Trehalose 19.8 ± 0.2
Total 116 ± 5
Tocopherols Content (µg g−1 lyophilized decoction)
α-Tocopherol 0.44 ± 0.02
γ-Tocopherol 1.43 ± 0.05
Total 1.87 ± 0.03
Table 2 Phenolic compound quantiﬁcation in M. oﬃcinalis decoctions
Phenolic compound
Content (mg g−1
lyophilized decoction)
3-(3,4-Dihydroxyphenyl)-lactic acid 6.5 ± 0.2
Caftaric acid 5.7 ± 0.1
Caﬀeic acid hexoside 1.1 ± 0.1
Fertaric acid 0.7 ± 0.1
Caﬀeic acid 2.2 ± 0.1
Sulphated rosmarinic acid 1.6 ± 0.2
Yunnaneic acid E 1.4 ± 0.1
Prolithospermic acid 2.2 ± 0.1
Lithospermic acid A isomer 62.5 ± 0.3
Chicoric acid 3.8 ± 0.1
Salvianolic acid C derivative 4.1 ± 0.2
Rosmarinic acid hexoside 4.9 ± 0.4
Sagerinic acid 7.9 ± 0.3
cis-Rosmarinic acid 5.1 ± 0.2
trans-Rosmarinic acid 83 ± 1
Salvianolic acid A 6.2 ± 0.2
Salvianolic acid C derivative 7.8 ± 0.2
Lithospermic acid A 10.9 ± 0.3
Salvianolic acid A isomer 2.1 ± 0.1
Salvianolic acid C derivative 2.84 ± 0.02
Total phenolic compounds 223 ± 1
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inhibition capacity (Table 5). These diﬀerences could be
explained by the diﬀerent underlying mechanisms involved in
each type of the antioxidant reaction and the interaction
between radical and antioxidant species.37 To obtain a better
overview of the antioxidant power of the studied decoctions,
for the DPPH and reducing power assays, they yielded higher
activity (lower EC50 values) than the methanolic extracts of
M. oﬃcinalis36 and Chenopodium ambrosioides L.,9 infusions of
Cynara scolymus L., C. ambrosioides,9 Silybum marianum (L.)
Gaertn, and Cochlospermum angolensis Welw.,38 decoctions of
Chamaemelum nobile L.,11 J. regia,34 M. recutita,33 Ginkgo biloba
L.,39 Origanum vulgare L.,2 C. sativa flowers7 and Taraxacum
sect. Ruderalia.40
The antitumor activity was evaluated against human tumor
cell lines, namely against breast (MCF-7), non-small lung
(NCI-H460), cervical (HeLa) and hepatocellular carcinoma
(HepG2) (Table 5). The best inhibition was detected for the
MCF-7 cell line and the least aﬀected cell line was the
NCI-H460. Although not outstandingly low when compared to
the positive control (ellipticine), the decoctions did not show
any hepatotoxicity (tested against the porcine liver cell primary
culture PLP2), while ellipticine had very strong toxic eﬀects. By
comparing their antitumor activity to other decocted and
infused plant samples, M. oﬃcinalis proved to be better
against the HepG2 cell line than hepatoprotective plants such
as S. marianum and C. angolensis,38 C. nobile,11 C. ambro-
sioides,9 J. regia34 and M. recutita.33 Furthermore, the four
latter species had higher GI50 for all the assayed cell lines,
when compared to M. oﬃcinalis.
4. Conclusions
M. oﬃcinalis decoctions proved to be a very good source of ros-
marinic acid and lithospermic acid A, quinic acid and γ-toco-
pherol. Rosmarinic acid might be one of the compounds
responsible for the various bioactive properties attributed to
lemon balm including the antibacterial and antioxidant
Table 4 Minimum inhibitory (MIC) and bactericidal (MBC) or fungicidal (MFC) concentrations of M. oﬃcinalis lyophilized decoctions, expressed in
mg mL−1
Bacterial species
M. oﬃcinalis decoction Streptomycin Ampicillin
MIC MIC MIC
MBC MBC MBC
Staphylococcus aureus 0.30 0.04 0.25
0.40 0.10 0.40
Bacillus cereus 0.40 0.10 0.25
0.75 0.20 0.40
Micrococcus flavus 0.75 0.20 0.25
1.50 0.30 0.40
Listeria monocytogenes 1.00 0.20 0.40
1.50 0.30 0.50
Pseudomonas aeruginosa 0.20 0.20 0.75
0.40 0.30 1.20
Escherichia coli 0.50 0.20 0.40
0.75 0.30 0.50
Enterobacter cloacae 0.50 0.20 0.25
0.75 0.30 0.50
Salmonella typhimurium 0.20 0.25 0.40
0.40 0.50 0.75
Fungal species
M. oﬃcinalis decoction Bifonazole Ketoconazole
MIC MIC MIC
MFC MFC MFC
Aspergillus fumigatus 0.40 0.15 0.20
0.75 0.20 0.50
Aspergillus versicolor 0.20 0.10 0.20
0.40 0.20 0.50
Aspergillus ochraceus 0.40 0.15 1.50
0.75 0.20 2.00
Aspergillus niger 0.40 0.15 0.20
0.75 0.20 0.50
Trichoderma viride 0.20 0.15 1.00
0.40 0.20 1.00
Penicillium funiculosum 0.10 0.20 0.20
0.20 0.25 0.50
Penicillium ochrochloron 0.40 0.20 2.50
0.75 0.25 3.50
Penicillium verrucosum 0.75 0.10 0.20
1.50 0.20 0.30
Paper Food & Function
2246 | Food Funct., 2015, 6, 2240–2248 This journal is © The Royal Society of Chemistry 2015
Pu
bl
ish
ed
 o
n 
01
 Ju
ne
 2
01
5.
 D
ow
nl
oa
de
d 
by
 In
sti
tu
to
 P
ol
ite
cn
ic
o 
de
 B
ra
ga
nc
a o
n 
26
/1
1/
20
15
 1
1:
09
:5
5.
 
View Article Online
eﬀects. The antimicrobial activity of the decoctions was
observed against a variety of bacteria and fungi, supporting
the claims as an antiseptic, especially against P. aeruginosa,
S. typhimurium and P. funiculosum. The antioxidant activity was
also outstanding, due to the very low EC50 values obtained for
DPPH scavenging activity and reducing power, placing the
decoctions of this medicinal plant as one of the most powerful
antioxidants assayed, supporting their consumption as a func-
tional beverage against oxidative stress. Finally, the activity
against specific tumor cell lines proved to be quite satisfactory,
yielding lower GI50 values, especially against HepG2 cell lines,
when compared to some hepatoprotective plants. No hepato-
toxicity was observed for the studied decoctions, which favours
their consumption as functional beverages, given their
pleasant taste.
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